Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli-Reference-Cited by-同舟云学术

Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli

Published:2021-05 Issue:3 Volume:62 Page:271-277
ISSN:1875-9572
Container-title:Pediatrics & Neonatology
language:en
Short-container-title:Pediatrics & Neonatology

Author:

Jo Kyo Jin^ORCID,Yoo Sukdong,Song Ji Yeon,Kim Seong Heon,Park Su Eun^ORCID

Funder

Pusan National University

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference39 articles.

1. Incidence and predictors of serious bacterial infections among 57- to 180-day-old infants;Hsiao;Pediatrics,2006

2. Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature;Huppler;Pediatrics,2010

3. Diagnosis and management of pediatric urinary tract infections;Zorc;Clin Microbiol Rev,2005

4. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy;Meier;Infection,2011

5. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria;Briongos-Figuero;Int J Clin Pract,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary Tract Infections among Febrile Infants in Qatar: Extended-Spectrum-Beta-Lactamase (ESBL)-Producing Versus Non-ESBL Organisms;Antibiotics;2024-06-12

2. Prevalence, Predictors, and Cross-Resistance of Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacterales in Pediatric Urinary Tract Infections in Israel;Clinical Pediatrics;2024-03-29

3. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in community-acquired urinary tract infections in children and susceptibility to commonly used antibiotic treatments;2023-01-06

4. Isolation and characterization of two novel phages as a possible therapeutic alternative against multi-drug resistant E. coli;Gene Reports;2022-09

5. Characterization of Primary Action Mode of Eight Essential Oils and Evaluation of Their Antibacterial Effect against Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Inoculated in Turkey Meat;Molecules;2022-04-18